These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3680030)

  • 21. Methotrexate: suppression of experimental allergic encephalomyelitis.
    BRANDRISS MW
    Science; 1963 Apr; 140(3563):186-7. PubMed ID: 14014958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Suppressant effect of unrelated antigens on the development of allergic encephalomyelitis].
    Zhitnukhin IuL; Karasik OA; Sofronov BN
    Patol Fiziol Eksp Ter; 1978; (4):58-61. PubMed ID: 704163
    [No Abstract]   [Full Text] [Related]  

  • 23. Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-alpha-ethinylestradiol: an immunological study in the Lewis rat.
    Trooster WJ; Teelken AW; Kampinga J; Loof JG; Nieuwenhuis P; Minderhoud JM
    Int Arch Allergy Immunol; 1993; 102(2):133-40. PubMed ID: 8400893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of immunological tolerance to brain antigens as a means of specific prevention and treatment of experimental allergic encephalomyelitis].
    Reber NV
    Biull Eksp Biol Med; 1971 Nov; 72(11):69-73. PubMed ID: 5131039
    [No Abstract]   [Full Text] [Related]  

  • 25. Antigen-induced inhibition of experimental allergic encephalomyelitis. I. Inhibition in guinea pigs injected with non-encephalitogenic modified myelin basic protein.
    Swanborg RH
    J Immunol; 1972 Sep; 109(3):540-6. PubMed ID: 4626655
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental allergic encephalomyelitis in inbred guinea pigs: correlation of decrease in early T cells with clinical signs in suppressed and unsuppressed animals.
    Traugott U; Raine CS
    Cell Immunol; 1977 Nov; 34(1):146-55. PubMed ID: 303153
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of experimental allergic encephalomyelitis by immunological technics].
    Pellet H; Brun M; Camargo R; Girard P
    Rev Neurol (Paris); 1968 Feb; 118(2):133-40. PubMed ID: 4301748
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunological studies on experimental allergic encephalomyelitis (EAE). Protection against EAE (author's transl)].
    Nagasawa K
    Fukuoka Igaku Zasshi; 1976 Jun; 67(6):220-33. PubMed ID: 986997
    [No Abstract]   [Full Text] [Related]  

  • 29. Suppression of experimental "allergic" encephalomyelitis in guinea pigs by encephalitogenic proteins extracted from homologous brain.
    SHAW CM; FAHLBERG WJ; KIES MW; ALVORD EC
    J Exp Med; 1960 Feb; 111(2):171-80. PubMed ID: 13831267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein.
    Lisak RP; Falk GA; Heinze RG; Kies MW; Alvord EC
    J Immunol; 1970 Jun; 104(6):1435-46. PubMed ID: 4986769
    [No Abstract]   [Full Text] [Related]  

  • 31. SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ANTIMETABOLITIES.
    BRANDRISS MW; SMITH JW; FRIEDMAN RM
    Ann N Y Acad Sci; 1965 Mar; 122():356-68. PubMed ID: 14313495
    [No Abstract]   [Full Text] [Related]  

  • 32. The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.
    Mertin J; Stackpoole A
    Clin Exp Immunol; 1979 Jun; 36(3):449-55. PubMed ID: 487646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Protective action of antioxidant preparations on the development of experimental allergic encephalomyelitis in guinea pigs].
    Kryzhanovskiĭ GN; Vilkov GA; Stepanenko EM
    Biull Eksp Biol Med; 1984 Nov; 98(11):527-30. PubMed ID: 6509167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of rats from experimental allergic encephalomyelitis with antiserum to guinea-pig spinal cord.
    Hughes RA
    Immunology; 1974 Apr; 26(4):703-11. PubMed ID: 4212280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of experimental allergic encephalomyelitis in guinea pigs.
    FERRARO A; CAZZULLO CL
    J Neuropathol Exp Neurol; 1949 Jan; 8(1):61-9. PubMed ID: 18123276
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of experimental allergic encephalomyelitis in guinea pigs.
    FERRARO A; CAZZULLO CL
    J Neuropathol Exp Neurol; 1949 Apr; 8(2):226-31. PubMed ID: 18118872
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen.
    Teitelbaum D; Webb C; Meshorer A; Arnon R; Sela M
    Eur J Immunol; 1973 May; 3(5):273-9. PubMed ID: 4128127
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis.
    Lisak RP; Zweiman B
    Cell Immunol; 1974 Nov; 14(2):242-54. PubMed ID: 4143110
    [No Abstract]   [Full Text] [Related]  

  • 39. Production of experimental allergic encephalomyelitis in guinea pigs via the intraperitoneal route.
    CAZZULLO CL; FERRARO A
    J Neuropathol Exp Neurol; 1949 Jan; 8(1):70-4. PubMed ID: 18108334
    [No Abstract]   [Full Text] [Related]  

  • 40. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
    Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
    Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.